4-Hydroxybutyric Acid
The risk or severity of adverse effects can be increased when Gamma Hydroxybutyric Acid is combined with Chlorphenamine.
Abiraterone
The serum concentration of Chlorphenamine can be increased when it is combined with Abiraterone.
Acepromazine
The risk or severity of adverse effects can be increased when Chlorphenamine is combined with Acepromazine.
Advertisement
Aceprometazine
The risk or severity of adverse effects can be increased when Chlorphenamine is combined with Aceprometazine.
Acetyl Sulfisoxazole
The metabolism of Chlorphenamine can be decreased when combined with Acetyl sulfisoxazole.
Alfaxalone
The risk or severity of adverse effects can be increased when Chlorphenamine is combined with Alfaxalone.
Advertisement
Alfentanil
The risk or severity of adverse effects can be increased when Alfentanil is combined with Chlorphenamine.
Alphaprodine
The risk or severity of adverse effects can be increased when Chlorphenamine is combined with Alphaprodine.
Alprazolam
The risk or severity of adverse effects can be increased when Alprazolam is combined with Chlorphenamine.
Advertisement
Amiodarone
The metabolism of Chlorphenamine can be decreased when combined with Amiodarone.
Amisulpride
The risk or severity of adverse effects can be increased when Chlorphenamine is combined with Amisulpride.
Amitriptyline
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Chlorphenamine.
Amobarbital
The risk or severity of adverse effects can be increased when Amobarbital is combined with Chlorphenamine.
Amoxapine
The risk or severity of adverse effects can be increased when Amoxapine is combined with Chlorphenamine.
Amphetamine
Amphetamine may decrease the sedative activities of Chlorphenamine.
Apalutamide
The serum concentration of Chlorphenamine can be decreased when it is combined with Apalutamide.
Aprepitant
The serum concentration of Chlorphenamine can be increased when it is combined with Aprepitant.
Aripiprazole
The risk or severity of adverse effects can be increased when Aripiprazole is combined with Chlorphenamine.
Artemether
The metabolism of Chlorphenamine can be decreased when combined with Artemether.
Articaine
The risk or severity of adverse effects can be increased when Chlorphenamine is combined with Articaine.
Asenapine
The risk or severity of adverse effects can be increased when Asenapine is combined with Chlorphenamine.
Atazanavir
The metabolism of Chlorphenamine can be decreased when combined with Atazanavir.
Atomoxetine
The metabolism of Chlorphenamine can be decreased when combined with Atomoxetine.
Azelastine
Chlorphenamine may increase the central nervous system depressant (CNS depressant) activities of Azelastine.
Baclofen
The risk or severity of adverse effects can be increased when Baclofen is combined with Chlorphenamine.
Barbital
The risk or severity of adverse effects can be increased when Chlorphenamine is combined with Barbital.
Benoxinate
The risk or severity of adverse effects can be increased when Chlorphenamine is combined with Oxybuprocaine.
Benperidol
The risk or severity of adverse effects can be increased when Chlorphenamine is combined with Benperidol.
Benzocaine
The risk or severity of adverse effects can be increased when Chlorphenamine is combined with Benzocaine.
Benzphetamine
Benzphetamine may decrease the sedative activities of Chlorphenamine.
Benzyl Alcohol
The risk or severity of adverse effects can be increased when Chlorphenamine is combined with Benzyl alcohol.
Benzylpenicilloyl polylysine
Chlorphenamine may decrease effectiveness of Benzylpenicilloyl Polylysine as a diagnostic agent.
BETAHISTINE
The therapeutic efficacy of Betahistine can be decreased when used in combination with Chlorphenamine.
Betaxolol
The metabolism of Chlorphenamine can be decreased when combined with Betaxolol.
Boceprevir
The metabolism of Chlorphenamine can be decreased when combined with Boceprevir.
Bortezomib
The metabolism of Chlorphenamine can be decreased when combined with Bortezomib.
Bosentan
The serum concentration of Chlorphenamine can be decreased when it is combined with Bosentan.
Bosentan Anhydrous
The serum concentration of Chlorphenamine can be decreased when it is combined with Bosentan.
Brexpiprazole
The risk or severity of adverse effects can be increased when Chlorphenamine is combined with Brexpiprazole.
Brimonidine
Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Chlorphenamine.
Bromazepam
The risk or severity of adverse effects can be increased when Bromazepam is combined with Chlorphenamine.
Bromperidol
The risk or severity of adverse effects can be increased when Chlorphenamine is combined with Bromperidol.
Brompheniramine
The risk or severity of adverse effects can be increased when Brompheniramine is combined with Chlorphenamine.
Brotizolam
The risk or severity of adverse effects can be increased when Chlorphenamine is combined with Brotizolam.
Bupivacaine
The risk or severity of adverse effects can be increased when Chlorphenamine is combined with Bupivacaine.
Buprenorphine
Chlorphenamine may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.
Bupropion
The metabolism of Chlorphenamine can be decreased when combined with Bupropion.
Buspirone
The risk or severity of adverse effects can be increased when Buspirone is combined with Chlorphenamine.
Butabarbital
The risk or severity of adverse effects can be increased when Butabarbital is combined with Chlorphenamine.
Butalbital
The risk or severity of adverse effects can be increased when Butalbital is combined with Chlorphenamine.
Butamben
The risk or severity of adverse effects can be increased when Chlorphenamine is combined with Butamben.
Butobarbital
The risk or severity of adverse effects can be increased when Chlorphenamine is combined with Butethal.
Butorphanol
The risk or severity of adverse effects can be increased when Butorphanol is combined with Chlorphenamine.
Carbamazepine
The metabolism of Chlorphenamine can be increased when combined with Carbamazepine.
Carbinoxamine
The risk or severity of adverse effects can be increased when Carbinoxamine is combined with Chlorphenamine.
Carisoprodol
The risk or severity of adverse effects can be increased when Carisoprodol is combined with Chlorphenamine.
Celecoxib
The metabolism of Chlorphenamine can be decreased when combined with Celecoxib.
Ceritinib
The serum concentration of Chlorphenamine can be increased when it is combined with Ceritinib.
Cetirizine
The risk or severity of adverse effects can be increased when Cetirizine is combined with Chlorphenamine.
Chloral Hydrate
The risk or severity of adverse effects can be increased when Chlorphenamine is combined with Chloral hydrate.
Chlordiazepoxide
The risk or severity of adverse effects can be increased when Chlordiazepoxide is combined with Chlorphenamine.
Chlormethiazole
The risk or severity of adverse effects can be increased when Chlorphenamine is combined with clomethiazole.
Chlormezanone
The risk or severity of adverse effects can be increased when Chlorphenamine is combined with Chlormezanone.
Chloroprocaine
The risk or severity of adverse effects can be increased when Chlorphenamine is combined with Chloroprocaine.
Chloroquine
The metabolism of Chlorphenamine can be decreased when combined with Chloroquine.
Chlorpromazine
The metabolism of Chlorphenamine can be decreased when combined with Chlorpromazine.
Chlorprothixene
The risk or severity of adverse effects can be increased when Chlorphenamine is combined with Chlorprothixene.
Chlorzoxazone
The risk or severity of adverse effects can be increased when Chlorzoxazone is combined with Chlorphenamine.
Cholecalciferol
The metabolism of Chlorphenamine can be decreased when combined with Cholecalciferol.
Cimetidine
The metabolism of Chlorphenamine can be decreased when combined with Cimetidine.
Cinacalcet
The metabolism of Chlorphenamine can be decreased when combined with Cinacalcet.
Citalopram
The metabolism of Chlorphenamine can be decreased when combined with Citalopram.
Clarithromycin
The metabolism of Chlorphenamine can be decreased when combined with Clarithromycin.
Clemastine
The metabolism of Chlorphenamine can be decreased when combined with Clemastine.
Clidinium
The risk or severity of adverse effects can be increased when Clidinium is combined with Chlorphenamine.
Clidinium bromide
The risk or severity of adverse effects can be increased when Clidinium is combined with Chlorphenamine.
Clobazam
The metabolism of Chlorphenamine can be decreased when combined with Clobazam.
Clomipramine
The metabolism of Chlorphenamine can be decreased when combined with Clomipramine.
Clonazepam
The risk or severity of adverse effects can be increased when Clonazepam is combined with Chlorphenamine.
Clonidine
The risk or severity of adverse effects can be increased when Clonidine is combined with Chlorphenamine.
Clorazepate
The risk or severity of adverse effects can be increased when Clorazepate is combined with Chlorphenamine.
CLORAZEPIC ACID
The risk or severity of adverse effects can be increased when Clorazepate is combined with Chlorphenamine.
Clotrimazole
The metabolism of Chlorphenamine can be decreased when combined with Clotrimazole.
Clozapine
The metabolism of Chlorphenamine can be decreased when combined with Clozapine.
Cobicistat
The serum concentration of Chlorphenamine can be increased when it is combined with Cobicistat.
Cocaine
The metabolism of Chlorphenamine can be decreased when combined with Cocaine.
Codeine
The risk or severity of adverse effects can be increased when Codeine is combined with Chlorphenamine.
Codeine Anhydrous
The risk or severity of adverse effects can be increased when Codeine is combined with Chlorphenamine.
CODEINE POLISTIREX
The risk or severity of adverse effects can be increased when Codeine is combined with Chlorphenamine.
Conivaptan
The serum concentration of Conivaptan can be increased when it is combined with Chlorphenamine.
Crizotinib
The metabolism of Chlorphenamine can be decreased when combined with Crizotinib.
Curcumin
The metabolism of Chlorphenamine can be decreased when combined with Curcumin.
Cyclizine
The risk or severity of adverse effects can be increased when Chlorphenamine is combined with Cyclizine.
Cyclobenzaprine
The risk or severity of adverse effects can be increased when Cyclobenzaprine is combined with Chlorphenamine.
Cyclosporine
The metabolism of Chlorphenamine can be decreased when combined with Cyclosporine.
Cyproheptadine
The risk or severity of adverse effects can be increased when Cyproheptadine is combined with Chlorphenamine.
Dabrafenib
The serum concentration of Chlorphenamine can be decreased when it is combined with Dabrafenib.
Dantrolene
The risk or severity of adverse effects can be increased when Chlorphenamine is combined with Dantrolene.
Dapiprazole
The risk or severity of adverse effects can be increased when Chlorphenamine is combined with Dapiprazole.
Darifenacin
The metabolism of Chlorphenamine can be decreased when combined with Darifenacin.
Darunavir
The serum concentration of Chlorphenamine can be increased when it is combined with Darunavir.
Dasatinib
The serum concentration of Chlorphenamine can be increased when it is combined with Dasatinib.
Dasatinib Anhydrous
The serum concentration of Chlorphenamine can be increased when it is combined with Dasatinib.
Deferasirox
The serum concentration of Chlorphenamine can be decreased when it is combined with Deferasirox.
Delavirdine
The metabolism of Chlorphenamine can be decreased when combined with Delavirdine.
Desflurane
The risk or severity of adverse effects can be increased when Desflurane is combined with Chlorphenamine.
Desipramine
The metabolism of Chlorphenamine can be decreased when combined with Desipramine.
Desloratadine
The risk or severity of adverse effects can be increased when Desloratadine is combined with Chlorphenamine.
Desvenlafaxine
The risk or severity of adverse effects can be increased when Chlorphenamine is combined with Desvenlafaxine.
Dexbrompheniramine
The risk or severity of adverse effects can be increased when Dexbrompheniramine is combined with Chlorphenamine.
Dexmedetomidine
The risk or severity of adverse effects can be increased when Chlorphenamine is combined with Dexmedetomidine.
Dextroamphetamine
Dextroamphetamine may decrease the sedative activities of Chlorphenamine.
Dextromoramide
The risk or severity of adverse effects can be increased when Chlorphenamine is combined with Dextromoramide.
Dezocine
The risk or severity of adverse effects can be increased when Chlorphenamine is combined with Dezocine.
Diazepam
The risk or severity of adverse effects can be increased when Diazepam is combined with Chlorphenamine.
Dibucaine
The risk or severity of adverse effects can be increased when Chlorphenamine is combined with Cinchocaine.
Diethylpropion
Diethylpropion may decrease the sedative activities of Chlorphenamine.
Difenoxin
The risk or severity of adverse effects can be increased when Chlorphenamine is combined with Difenoxin.
Dihydrocodeine
The risk or severity of adverse effects can be increased when Dihydrocodeine is combined with Chlorphenamine.
Dihydroergotamine
The metabolism of Chlorphenamine can be decreased when combined with Dihydroergotamine.
Diltiazem
The metabolism of Chlorphenamine can be decreased when combined with Diltiazem.
Dimenhydrinate
The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Chlorphenamine.
Diphenhydramine
The metabolism of Chlorphenamine can be decreased when combined with Diphenhydramine.
Diphenoxylate
The risk or severity of adverse effects can be increased when Diphenoxylate is combined with Chlorphenamine.
Dothiepin
The metabolism of Chlorphenamine can be decreased when combined with Dosulepin.
Doxepin
The risk or severity of adverse effects can be increased when Chlorphenamine is combined with Doxepin.
Doxycycline
The metabolism of Chlorphenamine can be decreased when combined with Doxycycline.
Doxycycline Anhydrous
The metabolism of Chlorphenamine can be decreased when combined with Doxycycline.
Doxylamine
Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Chlorphenamine.
Dronedarone
The metabolism of Chlorphenamine can be decreased when combined with Dronedarone.
Droperidol
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Chlorphenamine.
Duloxetine
The metabolism of Chlorphenamine can be decreased when combined with Duloxetine.
Dyclonine
The risk or severity of adverse effects can be increased when Chlorphenamine is combined with Dyclonine.
Efavirenz
The risk or severity of adverse effects can be increased when Efavirenz is combined with Chlorphenamine.
Eliglustat
The metabolism of Chlorphenamine can be decreased when combined with Eliglustat.
Enflurane
The risk or severity of adverse effects can be increased when Chlorphenamine is combined with Enflurane.
Entacapone
The risk or severity of adverse effects can be increased when Entacapone is combined with Chlorphenamine.
Enzalutamide
The serum concentration of Chlorphenamine can be decreased when it is combined with Enzalutamide.
Erythromycin
The metabolism of Chlorphenamine can be decreased when combined with Erythromycin.
Escitalopram
The risk or severity of adverse effects can be increased when Chlorphenamine is combined with Escitalopram.
Estazolam
The risk or severity of adverse effects can be increased when Estazolam is combined with Chlorphenamine.
Eszopiclone
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Chlorphenamine.
Ethanol
Chlorphenamine may increase the central nervous system depressant (CNS depressant) activities of Ethanol.
Ethchlorvynol
The risk or severity of adverse effects can be increased when Chlorphenamine is combined with Ethchlorvynol.
Ethosuximide
The risk or severity of adverse effects can be increased when Ethosuximide is combined with Chlorphenamine.
Ethotoin
The risk or severity of adverse effects can be increased when Ethotoin is combined with Chlorphenamine.
Ethyl Chloride
The risk or severity of adverse effects can be increased when Chlorphenamine is combined with Ethyl chloride.
Ethyl Loflazepate
The risk or severity of adverse effects can be increased when Chlorphenamine is combined with Ethyl loflazepate.
Ethylmorphine
The risk or severity of adverse effects can be increased when Chlorphenamine is combined with Ethylmorphine.
Etidocaine
The risk or severity of adverse effects can be increased when Chlorphenamine is combined with Etidocaine.
Etifoxine
The risk or severity of adverse effects can be increased when Chlorphenamine is combined with Etifoxine.
Etomidate
The risk or severity of adverse effects can be increased when Chlorphenamine is combined with Etomidate.
Ezogabine
The risk or severity of adverse effects can be increased when Chlorphenamine is combined with Ezogabine.
Felbamate
The risk or severity of adverse effects can be increased when Felbamate is combined with Chlorphenamine.
Fentanyl
The risk or severity of adverse effects can be increased when Fentanyl is combined with Chlorphenamine.
Fesoterodine
The serum concentration of the active metabolites of Fesoterodine can be increased when Fesoterodine is used in combination with Chlorphenamine.
Fexofenadine
The risk or severity of adverse effects can be increased when Fexofenadine is combined with Chlorphenamine.
Flibanserin
The risk or severity of adverse effects can be increased when Chlorphenamine is combined with Flibanserin.
Fluconazole
The metabolism of Chlorphenamine can be decreased when combined with Fluconazole.
Flunarizine
The risk or severity of adverse effects can be increased when Chlorphenamine is combined with Flunarizine.
Flunitrazepam
The risk or severity of adverse effects can be increased when Chlorphenamine is combined with Flunitrazepam.
Fluoxetine
The metabolism of Chlorphenamine can be decreased when combined with Fluoxetine.
Flupenthixol
The risk or severity of adverse effects can be increased when Flupentixol is combined with Chlorphenamine.
Fluphenazine
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Chlorphenamine.
Flurazepam
The risk or severity of adverse effects can be increased when Flurazepam is combined with Chlorphenamine.
Fluspirilene
The risk or severity of adverse effects can be increased when Chlorphenamine is combined with Fluspirilene.
Fluticasone propionate
The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Chlorphenamine.
Fluvoxamine
The metabolism of Chlorphenamine can be decreased when combined with Fluvoxamine.
Fosamprenavir
The metabolism of Chlorphenamine can be decreased when combined with Fosamprenavir.
Fosaprepitant
The serum concentration of Chlorphenamine can be increased when it is combined with Fosaprepitant.
Fosphenytoin
The serum concentration of Fosphenytoin can be increased when it is combined with Chlorphenamine.
Fospropofol
The risk or severity of adverse effects can be increased when Chlorphenamine is combined with Fospropofol.
Fusidate
The serum concentration of Chlorphenamine can be increased when it is combined with Fusidic Acid.
Fusidic Acid
The serum concentration of Chlorphenamine can be increased when it is combined with Fusidic Acid.
Gabapentin
The risk or severity of adverse effects can be increased when Gabapentin is combined with Chlorphenamine.
Gabapentin Enacarbil
The risk or severity of adverse effects can be increased when Chlorphenamine is combined with Gabapentin Enacarbil.
Glutethimide
The risk or severity of adverse effects can be increased when Chlorphenamine is combined with Glutethimide.
Guanfacine
The risk or severity of adverse effects can be increased when Guanfacine is combined with Chlorphenamine.
Halazepam
The risk or severity of adverse effects can be increased when Chlorphenamine is combined with Halazepam.
Haloperidol
The metabolism of Chlorphenamine can be decreased when combined with Haloperidol.
Halothane
The risk or severity of adverse effects can be increased when Chlorphenamine is combined with Halothane.
Heroin
The risk or severity of adverse effects can be increased when Chlorphenamine is combined with Heroin.
Hexobarbital
The risk or severity of adverse effects can be increased when Chlorphenamine is combined with Hexobarbital.
Hyaluronidase
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Chlorphenamine.
Hyaluronidase, Ovine
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Chlorphenamine.
Hydrocodone
Chlorphenamine may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.
HYDROCODONE POLISTIREX
Chlorphenamine may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.
Hydromorphone
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Chlorphenamine.
Hydroxyzine
Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Chlorphenamine.
Hypoxis hemerocallidea root extract
The serum concentration of Chlorphenamine can be decreased when it is combined with St. John's Wort.
Idelalisib
The metabolism of Chlorphenamine can be decreased when combined with Idelalisib.
Iloperidone
The risk or severity of adverse effects can be increased when Chlorphenamine is combined with Iloperidone.
Imatinib
The metabolism of Chlorphenamine can be decreased when combined with Imatinib.
Imipramine
The metabolism of Chlorphenamine can be decreased when combined with Imipramine.
Indinavir
The metabolism of Chlorphenamine can be decreased when combined with Indinavir.
INDINAVIR ANHYDROUS
The metabolism of Chlorphenamine can be decreased when combined with Indinavir.
Isavuconazole
The serum concentration of Chlorphenamine can be increased when it is combined with Isavuconazole.
Isavuconazonium
The metabolism of Chlorphenamine can be decreased when combined with Isavuconazonium.
Isoflurane
The risk or severity of adverse effects can be increased when Isoflurane is combined with Chlorphenamine.
Isoniazid
The metabolism of Chlorphenamine can be decreased when combined with Isoniazid.
Isradipine
The metabolism of Chlorphenamine can be decreased when combined with Isradipine.
Itraconazole
The metabolism of Chlorphenamine can be decreased when combined with Itraconazole.
Ivacaftor
The serum concentration of Chlorphenamine can be increased when it is combined with Ivacaftor.
Ketamine
The risk or severity of adverse effects can be increased when Ketamine is combined with Chlorphenamine.
Ketazolam
The risk or severity of adverse effects can be increased when Chlorphenamine is combined with Ketazolam.
Ketoconazole
The metabolism of Chlorphenamine can be decreased when combined with Ketoconazole.
Lamotrigine
The risk or severity of adverse effects can be increased when Lamotrigine is combined with Chlorphenamine.
Levetiracetam
The risk or severity of adverse effects can be increased when Chlorphenamine is combined with Levetiracetam.
Levobupivacaine
The risk or severity of adverse effects can be increased when Chlorphenamine is combined with Levobupivacaine.
Levocabastine
The risk or severity of adverse effects can be increased when Chlorphenamine is combined with Levocabastine.
Levocetirizine
The risk or severity of adverse effects can be increased when Chlorphenamine is combined with Levocetirizine.
Levodopa
The risk or severity of adverse effects can be increased when Chlorphenamine is combined with Levodopa.
Levomethadyl
The risk or severity of adverse effects can be increased when Chlorphenamine is combined with Levomethadyl Acetate.
Levomilnacipran
The risk or severity of adverse effects can be increased when Chlorphenamine is combined with Levomilnacipran.
Levorphanol
The risk or severity of adverse effects can be increased when Levorphanol is combined with Chlorphenamine.
Lidocaine
The risk or severity of adverse effects can be increased when Chlorphenamine is combined with Lidocaine.
Lisdexamfetamine
Lisdexamfetamine may decrease the sedative activities of Chlorphenamine.
Lisdexamfetamine Dimesylate
Lisdexamfetamine may decrease the sedative activities of Chlorphenamine.
Lithium
The risk or severity of adverse effects can be increased when Chlorphenamine is combined with Lithium.
Lithium Cation
The risk or severity of adverse effects can be increased when Chlorphenamine is combined with Lithium.
Lofexidine
The therapeutic efficacy of Chlorphenamine can be increased when used in combination with Lofexidine.
Lopinavir
The metabolism of Chlorphenamine can be decreased when combined with Lopinavir.
Loratadine
The risk or severity of adverse effects can be increased when Loratadine is combined with Chlorphenamine.
Lorazepam
The risk or severity of adverse effects can be increased when Lorazepam is combined with Chlorphenamine.
Lorcaserin
The metabolism of Chlorphenamine can be decreased when combined with Lorcaserin.
Lormetazepam
The risk or severity of adverse effects can be increased when Chlorphenamine is combined with Lormetazepam.
Lovastatin
The metabolism of Chlorphenamine can be decreased when combined with Lovastatin.
Loxapine
The risk or severity of adverse effects can be increased when Loxapine is combined with Chlorphenamine.
Luliconazole
The serum concentration of Chlorphenamine can be increased when it is combined with Luliconazole.
Lumacaftor
The metabolism of Chlorphenamine can be increased when combined with Lumacaftor.
Lumefantrine
The metabolism of Chlorphenamine can be decreased when combined with Lumefantrine.
Lurasidone
The risk or severity of adverse effects can be increased when Lurasidone is combined with Chlorphenamine.
Magnesium Sulfate
The therapeutic efficacy of Chlorphenamine can be increased when used in combination with Magnesium sulfate.
MAGNESIUM SULFATE ANHYDROUS
The therapeutic efficacy of Chlorphenamine can be increased when used in combination with Magnesium sulfate.
Manidipine
The metabolism of Chlorphenamine can be decreased when combined with Manidipine.
Maprotiline
The risk or severity of adverse effects can be increased when Maprotiline is combined with Chlorphenamine.
Meclizine
The risk or severity of adverse effects can be increased when Meclizine is combined with Chlorphenamine.
Melatonin
The risk or severity of adverse effects can be increased when Chlorphenamine is combined with Melatonin.
Meperidine
The risk or severity of adverse effects can be increased when Pethidine is combined with Chlorphenamine.
Mephentermine
Mephentermine may decrease the sedative activities of Chlorphenamine.
Mephobarbital
The risk or severity of adverse effects can be increased when Chlorphenamine is combined with Methylphenobarbital.
Mepivacaine
The risk or severity of adverse effects can be increased when Chlorphenamine is combined with Mepivacaine.
Meprobamate
The risk or severity of adverse effects can be increased when Meprobamate is combined with Chlorphenamine.
Mesoridazine
The risk or severity of adverse effects can be increased when Chlorphenamine is combined with Mesoridazine.
Metaxalone
The risk or severity of adverse effects can be increased when Metaxalone is combined with Chlorphenamine.
Methadone
The metabolism of Chlorphenamine can be decreased when combined with Methadone.
Methadyl Acetate
The risk or severity of adverse effects can be increased when Chlorphenamine is combined with Methadyl Acetate.
Methamphetamine
Methamphetamine may decrease the sedative activities of Chlorphenamine.
Methapyrilene
The risk or severity of adverse effects can be increased when Chlorphenamine is combined with Methapyrilene.
Methaqualone
The risk or severity of adverse effects can be increased when Chlorphenamine is combined with Methaqualone.
Methocarbamol
The risk or severity of adverse effects can be increased when Methocarbamol is combined with Chlorphenamine.
Methohexital
The risk or severity of adverse effects can be increased when Methohexital is combined with Chlorphenamine.
Methotrimeprazine
Chlorphenamine may increase the central nervous system depressant (CNS depressant) activities of Methotrimeprazine.
Methoxyflurane
The risk or severity of adverse effects can be increased when Chlorphenamine is combined with Methoxyflurane.
Methsuximide
The risk or severity of adverse effects can be increased when Chlorphenamine is combined with Methsuximide.
Metoprolol
The serum concentration of Metoprolol can be increased when it is combined with Chlorphenamine.
Metylperon
The risk or severity of adverse effects can be increased when Chlorphenamine is combined with Melperone.
Metyrosine
Chlorphenamine may increase the sedative activities of Metyrosine.
Midazolam
The risk or severity of adverse effects can be increased when Midazolam is combined with Chlorphenamine.
Midostaurin
The metabolism of Chlorphenamine can be decreased when combined with Midostaurin.
Mifepristone
The serum concentration of Chlorphenamine can be increased when it is combined with Mifepristone.
Milnacipran
The risk or severity of adverse effects can be increased when Chlorphenamine is combined with Milnacipran.
Minocycline
Minocycline may increase the central nervous system depressant (CNS depressant) activities of Chlorphenamine.
Mirabegron
The metabolism of Chlorphenamine can be decreased when combined with Mirabegron.
Mirtazapine
Chlorphenamine may increase the central nervous system depressant (CNS depressant) activities of Mirtazapine.
Mitotane
The serum concentration of Chlorphenamine can be decreased when it is combined with Mitotane.
Molindone
The risk or severity of adverse effects can be increased when Chlorphenamine is combined with Molindone.
Morphine
The risk or severity of adverse effects can be increased when Morphine is combined with Chlorphenamine.
Nabilone
Nabilone may increase the central nervous system depressant (CNS depressant) activities of Chlorphenamine.
Nalbuphine
The risk or severity of adverse effects can be increased when Nalbuphine is combined with Chlorphenamine.
Nefazodone
The metabolism of Chlorphenamine can be decreased when combined with Nefazodone.
Nelfinavir
The metabolism of Chlorphenamine can be decreased when combined with Nelfinavir.
Netupitant
The serum concentration of Chlorphenamine can be increased when it is combined with Netupitant.
Nevirapine
The metabolism of Chlorphenamine can be increased when combined with Nevirapine.
Nicardipine
The metabolism of Chlorphenamine can be decreased when combined with Nicardipine.
Nilotinib
The metabolism of Chlorphenamine can be decreased when combined with Nilotinib.
Nitrazepam
The risk or severity of adverse effects can be increased when Nitrazepam is combined with Chlorphenamine.
Nitrous Oxide
The risk or severity of adverse effects can be increased when Nitrous oxide is combined with Chlorphenamine.
Nordazepam
The risk or severity of adverse effects can be increased when Chlorphenamine is combined with Nordazepam.
Norflurane
The risk or severity of adverse effects can be increased when Chlorphenamine is combined with Norflurane.
Normethadone
The risk or severity of adverse effects can be increased when Chlorphenamine is combined with Normethadone.
Nortriptyline
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Chlorphenamine.
Olanzapine
The risk or severity of adverse effects can be increased when Olanzapine is combined with Chlorphenamine.
Olaparib
The metabolism of Chlorphenamine can be decreased when combined with Olaparib.
Olopatadine
The risk or severity of adverse effects can be increased when Olopatadine is combined with Chlorphenamine.
Ondansetron
The risk or severity of adverse effects can be increased when Chlorphenamine is combined with Ondansetron.
Opium
The risk or severity of adverse effects can be increased when Chlorphenamine is combined with Opium.
Orphenadrine
Chlorphenamine may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.
Osimertinib
The serum concentration of Chlorphenamine can be increased when it is combined with Osimertinib.
Oxazepam
The risk or severity of adverse effects can be increased when Oxazepam is combined with Chlorphenamine.
Oxprenolol
The risk or severity of adverse effects can be increased when Chlorphenamine is combined with Oxprenolol.
Oxycodone
The risk or severity of adverse effects can be increased when Oxycodone is combined with Chlorphenamine.
Oxymorphone
The risk or severity of adverse effects can be increased when Oxymorphone is combined with Chlorphenamine.
p-Hydroxyamphetamine
Hydroxyamphetamine may decrease the sedative activities of Chlorphenamine.
Palbociclib
The serum concentration of Chlorphenamine can be increased when it is combined with Palbociclib.
Paliperidone
The risk or severity of adverse effects can be increased when Paliperidone is combined with Chlorphenamine.
Panobinostat
The serum concentration of Chlorphenamine can be increased when it is combined with Panobinostat.
Paraldehyde
Chlorphenamine may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde.
Paregoric
The risk or severity of adverse effects can be increased when Morphine is combined with Chlorphenamine.
Paroxetine
The metabolism of Chlorphenamine can be decreased when combined with Paroxetine.
Peginterferon Alfa-2b
The serum concentration of Chlorphenamine can be decreased when it is combined with Peginterferon alfa-2b.
Pentazocine
The risk or severity of adverse effects can be increased when Pentazocine is combined with Chlorphenamine.
Pentobarbital
The metabolism of Chlorphenamine can be increased when combined with Pentobarbital.
Perampanel
Perampanel may increase the central nervous system depressant (CNS depressant) activities of Chlorphenamine.
Perazine
The risk or severity of adverse effects can be increased when Chlorphenamine is combined with Perazine.
Perphenazine
The risk or severity of adverse effects can be increased when Perphenazine is combined with Chlorphenamine.
Phenobarbital
The metabolism of Chlorphenamine can be increased when combined with Phenobarbital.
Phenoxyethanol
The risk or severity of adverse effects can be increased when Chlorphenamine is combined with Phenoxyethanol.
Phentermine
Phentermine may decrease the sedative activities of Chlorphenamine.
PHENTERMINE RESIN
Phentermine may decrease the sedative activities of Chlorphenamine.
Phenytoin
The serum concentration of Phenytoin can be increased when it is combined with Chlorphenamine.
Pimozide
The risk or severity of adverse effects can be increased when Pimozide is combined with Chlorphenamine.
Pipamperone
The risk or severity of adverse effects can be increased when Chlorphenamine is combined with Pipamperone.
Pipothiazine
The risk or severity of adverse effects can be increased when Chlorphenamine is combined with Pipotiazine.
Pirinitramide
The risk or severity of adverse effects can be increased when Chlorphenamine is combined with Piritramide.
Pizotyline
The risk or severity of adverse effects can be increased when Chlorphenamine is combined with Pizotifen.
Pomalidomide
The risk or severity of adverse effects can be increased when Chlorphenamine is combined with Pomalidomide.
Posaconazole
The metabolism of Chlorphenamine can be decreased when combined with Posaconazole.
Pramipexole
Chlorphenamine may increase the sedative activities of Pramipexole.
Pramoxine
The risk or severity of adverse effects can be increased when Chlorphenamine is combined with Pramocaine.
Prazepam
The risk or severity of adverse effects can be increased when Chlorphenamine is combined with Prazepam.
Pregabalin
The therapeutic efficacy of Chlorphenamine can be increased when used in combination with Pregabalin.
Prilocaine
The risk or severity of adverse effects can be increased when Chlorphenamine is combined with Prilocaine.
Primidone
The metabolism of Chlorphenamine can be increased when combined with Primidone.
Procaine
The risk or severity of adverse effects can be increased when Chlorphenamine is combined with Procaine.
Prochlorperazine
The risk or severity of adverse effects can be increased when Prochlorperazine is combined with Chlorphenamine.
Promazine
The metabolism of Chlorphenamine can be decreased when combined with Promazine.
Promethazine
The risk or severity of adverse effects can be increased when Promethazine is combined with Chlorphenamine.
Proparacaine
The risk or severity of adverse effects can be increased when Chlorphenamine is combined with Proparacaine.
Propofol
The risk or severity of adverse effects can be increased when Propofol is combined with Chlorphenamine.
Propoxyphene
The risk or severity of adverse effects can be increased when Chlorphenamine is combined with Dextropropoxyphene.
Protriptyline
The risk or severity of adverse effects can be increased when Protriptyline is combined with Chlorphenamine.
Pseudoephedrine
Pseudoephedrine may decrease the sedative activities of Chlorphenamine.
Quazepam
The risk or severity of adverse effects can be increased when Quazepam is combined with Chlorphenamine.
Quetiapine
The risk or severity of adverse effects can be increased when Quetiapine is combined with Chlorphenamine.
Quetiapine fumarate
The risk or severity of adverse effects can be increased when Quetiapine is combined with Chlorphenamine.
Quinidine
The metabolism of Chlorphenamine can be decreased when combined with Quinidine.
Quinine
The metabolism of Chlorphenamine can be decreased when combined with Quinine.
Ramelteon
The risk or severity of adverse effects can be increased when Ramelteon is combined with Chlorphenamine.
Ranolazine
The metabolism of Chlorphenamine can be decreased when combined with Ranolazine.
Remifentanil
The risk or severity of adverse effects can be increased when Remifentanil is combined with Chlorphenamine.
Remoxipride
The risk or severity of adverse effects can be increased when Chlorphenamine is combined with Remoxipride.
Reserpine
The risk or severity of adverse effects can be increased when Reserpine is combined with Chlorphenamine.
Rifabutin
The metabolism of Chlorphenamine can be increased when combined with Rifabutin.
Rifampin
The metabolism of Chlorphenamine can be increased when combined with Rifampicin.
Rifapentine
The metabolism of Chlorphenamine can be increased when combined with Rifapentine.
Risperidone
The risk or severity of adverse effects can be increased when Risperidone is combined with Chlorphenamine.
Ritonavir
The metabolism of Chlorphenamine can be decreased when combined with Ritonavir.
Rolapitant
The metabolism of Chlorphenamine can be decreased when combined with Rolapitant.
Ropinirole
Chlorphenamine may increase the sedative activities of Ropinirole.
Ropivacaine
The risk or severity of adverse effects can be increased when Chlorphenamine is combined with Ropivacaine.
Rotigotine
Chlorphenamine may increase the sedative activities of Rotigotine.
Rucaparib
The metabolism of Chlorphenamine can be decreased when combined with Rucaparib.
Rufinamide
The risk or severity of adverse effects can be increased when Rufinamide is combined with Chlorphenamine.
Saquinavir
The metabolism of Chlorphenamine can be decreased when combined with Saquinavir.
Saquinavir Mesylate
The metabolism of Chlorphenamine can be decreased when combined with Saquinavir.
Sarilumab
The therapeutic efficacy of Chlorphenamine can be decreased when used in combination with Sarilumab.
Scopolamine
The risk or severity of adverse effects can be increased when Scopolamine is combined with Chlorphenamine.
Scopolamine Hydrobromide
The risk or severity of adverse effects can be increased when Scopolamine is combined with Chlorphenamine.
Secobarbital
The risk or severity of adverse effects can be increased when Secobarbital is combined with Chlorphenamine.
Sertindole
The risk or severity of adverse effects can be increased when Chlorphenamine is combined with Sertindole.
Sertraline
The metabolism of Chlorphenamine can be decreased when combined with Sertraline.
Sevoflurane
The risk or severity of adverse effects can be increased when Sevoflurane is combined with Chlorphenamine.
Sildenafil
The metabolism of Chlorphenamine can be decreased when combined with Sildenafil.
Siltuximab
The serum concentration of Chlorphenamine can be decreased when it is combined with Siltuximab.
Simeprevir
The serum concentration of Chlorphenamine can be increased when it is combined with Simeprevir.
Sodium Oxybate
Sodium oxybate may increase the central nervous system depressant (CNS depressant) activities of Chlorphenamine.
ST. JOHN'S WORT EXTRACT
The serum concentration of Chlorphenamine can be decreased when it is combined with St. John's Wort.
Sufentanil
The risk or severity of adverse effects can be increased when Sufentanil is combined with Chlorphenamine.
Sulfisoxazole
The metabolism of Chlorphenamine can be decreased when combined with Sulfisoxazole.
Sulpiride
The risk or severity of adverse effects can be increased when Chlorphenamine is combined with Sulpiride.
Suvorexant
Chlorphenamine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.
Tapentadol
Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Chlorphenamine.
Tasimelteon
The risk or severity of adverse effects can be increased when Chlorphenamine is combined with Tasimelteon.
Telaprevir
The metabolism of Chlorphenamine can be decreased when combined with Telaprevir.
Telithromycin
The metabolism of Chlorphenamine can be decreased when combined with Telithromycin.
Temazepam
The risk or severity of adverse effects can be increased when Temazepam is combined with Chlorphenamine.
Terbinafine
The metabolism of Chlorphenamine can be decreased when combined with Terbinafine.
Tetrabenazine
The risk or severity of adverse effects can be increased when Chlorphenamine is combined with Tetrabenazine.
Tetracaine
The risk or severity of adverse effects can be increased when Chlorphenamine is combined with Tetracaine.
Tetracaine hydrochloride
The risk or severity of adverse effects can be increased when Chlorphenamine is combined with Tetracaine.
Tetrahydrocannabinol
Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Chlorphenamine.
Thalidomide
Chlorphenamine may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Thiamylal
The risk or severity of adverse effects can be increased when Chlorphenamine is combined with Thiamylal.
Thiopental
The risk or severity of adverse effects can be increased when Chlorphenamine is combined with Thiopental.
Thiopental Sodium
The risk or severity of adverse effects can be increased when Chlorphenamine is combined with Thiopental.
Thioridazine
Chlorphenamine may increase the arrhythmogenic activities of Thioridazine.
Thiothixene
The risk or severity of adverse effects can be increased when Thiothixene is combined with Chlorphenamine.
Tiagabine
The risk or severity of adverse effects can be increased when Tiagabine is combined with Chlorphenamine.
Tiapride
The risk or severity of adverse effects can be increased when Chlorphenamine is combined with Tiapride.
Ticlopidine
The metabolism of Chlorphenamine can be decreased when combined with Ticlopidine.
Tipranavir
The metabolism of Chlorphenamine can be decreased when combined with Tipranavir.
Tizanidine
The risk or severity of adverse effects can be increased when Tizanidine is combined with Chlorphenamine.
Tocilizumab
The serum concentration of Chlorphenamine can be decreased when it is combined with Tocilizumab.
Tolcapone
The risk or severity of adverse effects can be increased when Tolcapone is combined with Chlorphenamine.
Topiramate
The risk or severity of adverse effects can be increased when Topiramate is combined with Chlorphenamine.
Tramadol
The risk or severity of adverse effects can be increased when Tramadol is combined with Chlorphenamine.
Tranylcypromine
The metabolism of Chlorphenamine can be decreased when combined with Tranylcypromine.
Trazodone
The risk or severity of adverse effects can be increased when Chlorphenamine is combined with Trazodone.
Triazolam
The risk or severity of adverse effects can be increased when Triazolam is combined with Chlorphenamine.
Triazulenone
The risk or severity of adverse effects can be increased when Chlorphenamine is combined with Loprazolam.
Trifluoperazine
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Chlorphenamine.
Triflupromazine
The risk or severity of adverse effects can be increased when Chlorphenamine is combined with Triflupromazine.
Trimipramine
The risk or severity of adverse effects can be increased when Trimipramine is combined with Chlorphenamine.
Triprolidine
The risk or severity of adverse effects can be increased when Triprolidine is combined with Chlorphenamine.
Tryptophan
L-Tryptophan may increase the serotonergic activities of Chlorphenamine.
Urethane
The risk or severity of adverse effects can be increased when Chlorphenamine is combined with Ethyl carbamate.
Valproate
The risk or severity of adverse effects can be increased when Chlorphenamine is combined with Valproic Acid.
Valproic Acid
The risk or severity of adverse effects can be increased when Chlorphenamine is combined with Valproic Acid.
Vemurafenib
The serum concentration of Chlorphenamine can be decreased when it is combined with Vemurafenib.
Venlafaxine
The metabolism of Chlorphenamine can be decreased when combined with Venlafaxine.
Verapamil
The metabolism of Chlorphenamine can be decreased when combined with Verapamil.
Vigabatrin
The risk or severity of adverse effects can be increased when Vigabatrin is combined with Chlorphenamine.
Voriconazole
The metabolism of Chlorphenamine can be decreased when combined with Voriconazole.
Vortioxetine
The risk or severity of adverse effects can be increased when Chlorphenamine is combined with Vortioxetine.
Xylazine
The risk or severity of adverse effects can be increased when Chlorphenamine is combined with Xylazine.
Zaleplon
The risk or severity of adverse effects can be increased when Zaleplon is combined with Chlorphenamine.
Ziconotide
The risk or severity of adverse effects can be increased when Chlorphenamine is combined with Ziconotide.
Ziprasidone
The metabolism of Chlorphenamine can be decreased when combined with Ziprasidone.
Zolpidem
Chlorphenamine may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.
Zonisamide
The risk or severity of adverse effects can be increased when Zonisamide is combined with Chlorphenamine.
Zopiclone
The risk or severity of adverse effects can be increased when Zopiclone is combined with Chlorphenamine.
Zotepine
The risk or severity of adverse effects can be increased when Chlorphenamine is combined with Zotepine.
Zuclopenthixol
The risk or severity of adverse effects can be increased when Zuclopenthixol is combined with Chlorphenamine.
